← All cap tiers
Cap tier

Micro Cap

Every analyzed stock in Micro Cap3,022 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

AACB
Artius II Acquisition Inc.
Valuation N/A
Financial Services
Price$10.52
Model IV
P/IV
Limited data — see page
AACBR
Artius II Acquisition Inc.
Valuation N/A
Financial Services
Price$0.19
Model IV
P/IV
Limited data — see page
AACG
ATA Creativity Global
Valuation N/A
Consumer Defensive
Price$1.04
Model IV
P/IV
Market implies +24.4%/yr vs model +4.8% · above model
AACI
Armada Acquisition Corp. III
Valuation N/A
Financial Services
Price$10.00
Model IV
P/IV
Limited data — see page
AACO
Abony Acquisition Corp. I
Valuation N/A
Financial Services
Price$9.95
Model IV
P/IV
Limited data — see page
AACP
Apogee Acquisition Corp
Valuation N/A
Financial Services
Price$9.97
Model IV
P/IV
Limited data — see page
AAME
ATLANTIC AMERICAN CORP
Undervalued
Financial Services
Price$1.71
Model IV$2.38
P/IV0.91
Discount 28% Return to IV: +39.0%
Market implies -19.6%/yr vs model +2.0% · below model
AARD
Aardvark Therapeutics, Inc.
Valuation N/A
Healthcare
Price$5.70
Model IV
P/IV
Limited data — see page
ABLV
Able View Global Inc.
Deep Overvalued
Consumer Cyclical
Price$1.19
Model IV$0.40
P/IV2.75
Premium +198% Return to IV: -66.4%
Market implies +14.6%/yr vs model +3.0% · above model
ABOS
Acumen Pharmaceuticals, Inc.
Valuation N/A
Healthcare
Price$2.74
Model IV
P/IV
Limited data — see page
ABTC
American Bitcoin Corp.
Deep Overvalued
Financial Services
Price$0.56
Model IV$0.31
P/IV3.59
Premium +79% Return to IV: -44.0%
Market implies +14.8%/yr vs model +50.0% · below model
ABTS
Abits Group Inc
Deep Undervalued
Financial Services
Price$1.17
Model IV$3.57
P/IV0.23
Discount 67% Return to IV: +205.1%
Market implies -18.4%/yr vs model +46.0% · below model
ABVC
ABVC BIOPHARMA, INC.
Valuation N/A
Healthcare
Price$1.80
Model IV
P/IV
Market implies +72.0%/yr vs model +2.0% · above model
ABVE
Above Food Ingredients Inc.
Valuation N/A
Consumer Defensive
Price$0.11
Model IV
P/IV
Limited data — see page
ACAA
Averin Capital Acquisition Corp.
Valuation N/A
Financial Services
Price$10.20
Model IV
P/IV
Limited data — see page
ACB
AURORA CANNABIS INC
Valuation N/A
Healthcare
Price$2.84
Model IV
P/IV
Limited data — see page
ACCL
Acco Group Holdings Ltd
Undervalued
Industrials
Price$1.72
Model IV$2.39
P/IV0.63
Discount 28% Return to IV: +38.7%
Market implies +1.8%/yr vs model +12.2% · below model
ACCS
ACCESS Newswire Inc.
Overvalued
Industrials
Price$6.89
Model IV$5.66
P/IV1.14
Premium +22% Return to IV: -17.8%
Market implies -6.9%/yr vs model +2.0% · below model
ACET
Adicet Bio, Inc.
Valuation N/A
Healthcare
Price$9.00
Model IV
P/IV
Limited data — see page
ACFN
ACORN ENERGY, INC.
Deep Overvalued
Industrials
Price$16.89
Model IV$11.21
P/IV1.52
Premium +51% Return to IV: -33.6%
Market implies +11.0%/yr vs model +11.7% · in line
ACGC
ACP Holdings Acquisition Corp.
Valuation N/A
Financial Services
Price$9.96
Model IV
P/IV
Limited data — see page
ACH
ACCENDRA HEALTH INC/VA/
Deep Undervalued
Industrials
Price$3.59
Model IV$9.86
P/IV0.29
Discount 64% Return to IV: +174.7%
Market implies -18.7%/yr vs model +2.0% · below model
ACIU
AC Immune SA
Valuation N/A
Healthcare
Price$2.51
Model IV
P/IV
Limited data — see page
ACNT
ASCENT INDUSTRIES CO.
Overvalued
Basic Materials
Price$15.26
Model IV$12.11
P/IV1.12
Premium +26% Return to IV: -20.6%
Market implies -1.8%/yr vs model +0.0% · in line
ACOG
Alpha Cognition Inc.
Valuation N/A
Healthcare
Price$7.89
Model IV
P/IV
Market implies +28.3%/yr vs model +15.0% · above model
ACON
Aclarion, Inc.
Valuation N/A
Healthcare
Price$3.09
Model IV
P/IV
Market implies +34.6%/yr vs model +5.9% · above model
ACONW
Aclarion, Inc.
Deep Overvalued
Healthcare
Price$0.02
Model IV$0.01
P/IV3.13
Premium +131% Return to IV: -56.7%
Market implies +12.5%/yr vs model +2.0% · above model
ACP
abrdn Income Credit Strategies Fund
Valuation N/A
Unknown
Price$5.28
Model IV
P/IV
Limited data — see page
ACR
ACRES Commercial Realty Corp.
Deep Overvalued
Financial Services
Price$18.00
Model IV$8.28
P/IV2.46
Premium +117% Return to IV: -54.0%
Market implies +10.7%/yr vs model +3.0% · above model
ACRE
Ares Commercial Real Estate Corp
Deep Undervalued
Financial Services
Price$4.52
Model IV$6.70
P/IV0.74
Discount 33% Return to IV: +48.2%
Market implies -7.6%/yr vs model +1.0% · below model
ACRV
Acrivon Therapeutics, Inc.
Valuation N/A
Healthcare
Price$1.72
Model IV
P/IV
Limited data — see page
ACTG
ACACIA RESEARCH CORP
Deep Overvalued
Financial Services
Price$4.54
Model IV$0.99
P/IV2.54
Premium +357% Return to IV: -78.1%
Market implies +20.8%/yr vs model +3.0% · above model
ACTU
ACTUATE THERAPEUTICS, INC.
Valuation N/A
Healthcare
Price$1.52
Model IV
P/IV
Limited data — see page
ACU
ACME UNITED CORP
Deep Overvalued
Industrials
Price$47.61
Model IV$16.96
P/IV2.49
Premium +181% Return to IV: -64.4%
Market implies +14.5%/yr vs model +3.2% · above model
ACV
Virtus Diversified Income & Convertible Fund
Valuation N/A
Unknown
Price$28.03
Model IV
P/IV
Limited data — see page
ACXP
Acurx Pharmaceuticals, Inc.
Valuation N/A
Healthcare
Price$1.60
Model IV
P/IV
Limited data — see page
ADAC
American Drive Acquisition Co
Valuation N/A
Financial Services
Price$10.07
Model IV
P/IV
Limited data — see page
ADAG
Adagene Inc.
Valuation N/A
Healthcare
Price$4.47
Model IV
P/IV
Market implies +49.4%/yr vs model +2.0% · above model
ADGM
Adagio Medical Holdings, Inc.
Valuation N/A
Healthcare
Price$0.64
Model IV
P/IV
Market implies +44.5%/yr vs model +15.0% · above model
ADIL
ADIAL PHARMACEUTICALS, INC.
Valuation N/A
Healthcare
Price$2.90
Model IV
P/IV
Limited data — see page
ADSEW
Ads-Tec Energy Public Ltd Co
Valuation N/A
Technology
Price$0.65
Model IV
P/IV
Limited data — see page
ADT
ADT Inc.
Valuation N/A
Technology
Price$6.83
Model IV
P/IV
Limited data — see page
ADTX
Aditxt, Inc.
Deep Undervalued
Healthcare
Price$0.01
Model IV$0.03
P/IV3.91
Discount 83% Return to IV: +483.1%
ADVB
Advanced Biomed Inc.
Valuation N/A
Healthcare
Price$4.99
Model IV
P/IV
Limited data — see page
ADX
ADAMS DIVERSIFIED EQUITY FUND, INC.
Valuation N/A
Unknown
Price$25.59
Model IV
P/IV
Limited data — see page
AEAQ
Activate Energy Acquisition Corp.
Valuation N/A
Financial Services
Price$10.00
Model IV
P/IV
Limited data — see page
AEC
ANFIELD ENERGY INC.
Valuation N/A
Basic Materials
Price$4.22
Model IV
P/IV
Limited data — see page
AEF
abrdn Emerging Markets ex-China Fund, Inc.
Valuation N/A
Unknown
Price$9.19
Model IV
P/IV
Limited data — see page
AEFC
AEGON LTD.
Valuation N/A
Financial Services
Price$18.81
Model IV
P/IV
Limited data — see page
AEG
AEGON LTD.
Valuation N/A
Financial Services
Price$8.66
Model IV
P/IV
Limited data — see page
AEHL
Antelope Enterprise Holdings Ltd
Valuation N/A
Communication Services
Price$1.00
Model IV
P/IV
Limited data — see page
AEI
Alset Inc.
Valuation N/A
Real Estate
Price$1.34
Model IV
P/IV
Market implies +35.0%/yr vs model +2.0% · above model
AEMD
AETHLON MEDICAL INC
Valuation N/A
Healthcare
Price$0.71
Model IV
P/IV
Market implies +5.9%/yr vs model +15.0% · below model
AENTW
ALLIANCE ENTERTAINMENT HOLDING CORP
Deep Undervalued
Industrials
Price$0.43
Model IV$18.43
P/IV0.03
Discount 98% Return to IV: +4,181.1%
Market implies -50.0%/yr vs model +6.0% · below model
AEON
AEON Biopharma, Inc.
Valuation N/A
Healthcare
Price$0.72
Model IV
P/IV
Limited data — see page
AERT
Aeries Technology, Inc.
Deep Overvalued
Industrials
Price$7.34
Model IV$0.65
P/IV1.15
Premium +1,025% Return to IV: -91.1%
Market implies +29.4%/yr vs model +15.0% · above model
AERTW
Aeries Technology, Inc.
Deep Undervalued
Industrials
Price$0.02
Model IV$5.29
P/IV0.00
Discount 100% Return to IV: +24,619.6%
Market implies -50.0%/yr vs model +36.6% · below model
AESP
Aeon Acquisition I Corp.
Valuation N/A
Financial Services
Price$9.87
Model IV
P/IV
Limited data — see page
AEXA
American Exceptionalism Acquisition Corp. A
Valuation N/A
Financial Services
Price$11.85
Model IV
P/IV
Limited data — see page
AEYE
AUDIOEYE INC
Deep Overvalued
Technology
Price$6.51
Model IV$4.42
P/IV1.74
Premium +47% Return to IV: -32.1%
Market implies +8.4%/yr vs model +13.3% · below model